Skip to main content
. 2022 Nov 10;13:953210. doi: 10.3389/fimmu.2022.953210

Figure 7.

Figure 7

Forest plot depicts a comparison of the incidence of acute antibody-mediated rejection (AMR) among LT recipients undergoing antiviral prophylaxis and preemptive therapy.